The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

Although compact Un1Cas12f1 has improved, low gene editing activity was observed ... Here, the authors develop a high-fidelity RNA-targeting CRISPR system to suppress the repeat RNA expressed ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

Synthego granted global license to manufacture and distribute AZ's CRISPR gene editing enzyme, eSpOT-ON.

Made by Bluebird Bio, it uses an older technology that introduces a new gene to treat the disease. Vertex Pharmaceuticals and Crispr Therapeutics ... collecting and editing a person’s stem ...